Stocktoria

Biomea Fusion, Inc. BMEA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-04-16

Biomea Fusion, Inc. statistics & valuation

Market cap$95.4M
P / B3.2×
Return on capital-175.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-103.00% -23.20% -75.40% -69.30% -268.40% -209.10% 202020212022202320242025
Shares outstanding
12.0M 29.1M 29.6M 35.9M 36.3M 72.3M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-8.50% -22.40% -63.30% -58.60% -173.20% -105.50% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.51 -$1.74 -$2.80 -$3.44 -$3.83 -$1.18 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-105.5%-173.2%-58.6%-63.3%-22.4%-8.5%
Return on equity-209.1%-268.4%-69.3%-75.4%-23.2%-103.0%
Current ratio5.233.157.846.1738.0838.43

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.